Skip to content

A quarter of HIV/HCV-co-infected people in EuroSIDA have received HCV therapy

Evidence is not yet sufficient to recommend universal treatment, clinicians and community writers say

HIV treatment has not led to increasing sexual risk-taking in rural South African communities

Opportunities being missed for a vaginal delivery for HIV-positive pregnant women in Europe with viral suppression

Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection

Drinking alcohol doesn't increase the risk of HIV treatment failure

Investigators identify genetic profile associated with better treatment outcomes in people with HIV/HCV co-infection

Lymphoma mortality rates remain elevated among HIV-positive people in the United States

Biomedical HIV prevention – the social complexities of achieving effectiveness

Professor Susan Kippax,  co-chair of the 2nd International Conference for the Social Sciences and Humanities in HIV. ©IAS/Marcus Rose/Worker's Photos.